PTEN and neoplasm: PTEN mutations have also been linked to a higher rate of ICI therapy resistance, suggesting an interplay between these mutations and an immunosuppressive tumor microenvironment (TME).9 Alterations of these pathways have also been explored in genitourinary cancers.